AVNR Financial Facts
Total operating expenses: 18.41MInterest income: 10.85K
See Full Income Statement
Accounts payable: 1.41M
Royalty receivables: 0
See Full Balance Sheet
Avanir Pharma (AVNR) Earnings
|
Expand Research on AVNR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -5.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
12/10/14  |
 |
Q414 | -$0.08 | -$0.06 | -$0.02 | $59.25M | $30.15M | N/A |  | | Details |
| 8/5/14 |
|
Q314 | -$0.08 | -$0.08 | $0.00 | N/A | $29.46M | N/A | | | Details |
| 5/6/14 |
|
Q214 | -$0.08 | -$0.08 | $0.00 | $26.9M | $28.21M | N/A | | | Details |
| 2/5/14 |
|
Q114 | -$0.07 | -$0.08 | +$0.01 | $26.7M | $24.84M | N/A | | | Details |
| 12/10/13 |
|
Q413 | -$0.10 | -$0.08 | -$0.02 | $21.7M | $21.86M | N/A | | | Details |
| 8/6/13 |
|
Q313 | -$0.08 | -$0.11 | +$0.03 | $19.8M | $19.53M | N/A | | | Details |
| 5/8/13 |
|
Q113 | -$0.12 | -$0.09 | -$0.03 | $17.4M | $17.4M | N/A | | | Details |
| 2/7/13 |
|
Q113 | -$0.09 | -$0.08 | -$0.01 | $16.5M | $7.2M | N/A | | | Details |
